This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ImmunoCellular Therapeutics Ltd (IMUC)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 27.65M 26.22M 6.65M 5.32M
Receivables n.a. 0.00 0.00 0.00
Inventories n.a. 0.00 0.00 0.00
Other Current Assets 763.30K 714.51K 91.29K 24.03K
Total Current Assets 28.41M 26.93M 6.74M 5.34M
Property, Plant & Equipment, Gross n.a. 151.57K 105.86K 12.37K
Accumulated Depreciation & Depletion n.a. 75.28K 29.46K 0.00
Property, Plant & Equipment, Net n.a. 76.29K 76.40K 12.37K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 531.03K 11.74K 329.90K 8.97K
Total Non-Current Assets 531.03K 88.02K 406.30K 21.34K
Liabilities & Shareholder Equity
Total Assets 28.94M 27.02M 7.15M 5.37M
Accounts Payable n.a. 732.85K 1.32M 171.06K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.40M 0.00 0.00 0.00
Total Current Liabilities 1.40M 1.10M 1.76M 447.45K
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 1.06M 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 2.85M 2.16M 2.58M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.06M 2.85M 2.16M 2.58M
Total Liabilities 2.47M 3.95M 3.92M 3.03M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 26.47M 23.07M 3.23M 2.34M
Common Par n.a. 5.15K 2.86K 2.22K
Additional Paid In Capital 0.00 66.23M 31.90M 25.34M
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 -43.17M -28.67M -22.95M
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 26.47M 0.00 0.00 -54.28K
Total Capitalization 26.47M 23.07M 3.23M 2.34M
Total Equity 26.47M 23.07M 3.23M 2.34M
Total Liabilities & Stock Equity 28.94M 27.02M 7.15M 5.37M
Total Common Shares Outstanding 57.10M 51.50M 28.61M 22.21M
Preferred Shares n.a. 0.00 152.00 152.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding n.a. 41.80M 27.45M 19.19M
Diluted Weighted Shares Outstanding n.a. 41.80M 27.45M 19.19M
Number of Employees NA 5 4 3
Number of Part-Time Employees NA 2 0 0
IMUC News

IMUC ImmunoCellular Therapeutics Ltd

Analysts Ratings for IMUC

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET IMUC ANALYST REPORT

Brokerage Partners

IMUC Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs